Vansen Pharma Inc. — key financial figures for fiscal year 2012 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2012)

-$250.1K

Total Assets (FY2012)

$15.0K

Total Equity (FY2012)

-$104.5K

Cash Flows from Operating Activities (FY2012)

-$28.8K

Source: Vansen Pharma Inc. 10-K filing (FY2012). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.